Drug Shortage Report for HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)

Last updated on 2022-08-18 History
Report ID 141775
Drug Identification Number 02303086
Brand name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Common or Proper name HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE)
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HEPARIN SODIUM
Strength(s) 1000UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS INTRAVENOUS
Packaging size 30ML 10 LIVI CA
ATC code B01AB
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-07-02
Estimated end date Unknown
Actual end date 2022-08-18
Shortage status Resolved
Updated date 2022-08-18
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2022-08-18 French Compare
v13 2022-08-18 English Compare
v12 2022-06-17 French Compare
v11 2022-06-17 English Compare
v10 2022-05-10 French Compare
v9 2022-05-10 English Compare
v8 2022-04-05 French Compare
v7 2022-04-05 English Compare
v6 2022-03-03 French Compare
v5 2022-03-03 English Compare
v4 2022-01-26 French Compare
v3 2022-01-26 English Compare
v2 2021-07-05 French Compare
v1 2021-07-05 English Compare

Showing 1 to 14 of 14